AI THERAPEUTICS

Trademark usage description

pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases, namely, amyotrophic lateral sclerosis, pulmonary arterial h Read More

Classification Information

Class [005]
Pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases, namely, Amyotrophic Lateral Sclerosis, Pulmonary Arterial Hypertension, Pulmonary Sarcoidosis, Bronchiolitis Obliterans; Pharmaceutical and biopharmaceutical preparations for the treatment of cancer and rare diseases, namely, Amyotrophic Lateral Sclerosis, Pulmonary Arterial Hypertension, Pulmonary Sarcoidosis, Bronchiolitis Obliterans;

Classification kind code

Class [042]
Medical, pharmaceutical, and biopharmaceutical research services; scientific research for medical purposes in the field of cancerous diseases; development of pharmaceutical preparations and medicines; research in the field of gene therapy; laboratory research in the field of gene expression; genetic engineering; scientific research in the field of genetics; scientific and medical research in the fields of gene, genome, and genomic editing, modulation, transcription, to develop human pharmaceutical and biopharmaceutical preparations

Classification kind code

Mark Details

Serial Number

1948681

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 20^th Dec 2024	Registration Pending
Submitted for opposition 42 on 2^th Oct 2024	Advertised
Submitted for opposition 26 on 9^th Sept 2024	Approved
Submitted for opposition 27 on 9^th Sept 2024	Approval Notice Sent
Submitted for opposition 67 on 29^th Sept 2023	Agent Name Changed
Submitted for opposition 22 on 4^th Nov 2022	Search Recorded
Submitted for opposition 20 on 4^th Nov 2022	Examiner's First Report
Submitted for opposition 31 on 6^th Mar 2019	Formalized
Submitted for opposition 1 on 28^th Feb 2019	Created
Submitted for opposition 30 on 27^th Feb 2019	Filed